Crossmark

Concomitant use of renin-angiotensin-aldosterone system inhibitors prevent trastuzumab-induced cardiotoxicity in HER2+ breast cancer patients: an institutional retrospective study

Crossref DOI link: https://doi.org/10.1186/s40959-019-0043-8

Published Online: 2019-07-08

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Moey, Melissa Y. Y. http://orcid.org/0000-0002-8117-0487
Liles, Darla K.

Carabello, Blase A.
License Information

Text and Data Mining valid from 2019-07-08

Version of Record valid from 2019-07-08
More Information

Article History

Received: 6 February 2019

Accepted: 26 June 2019

First Online: 8 July 2019

Ethics approval and consent to participate

: The Institutional Review Board (IRB) of East Carolina University approved the project and waived the requirement for consent.

: Not applicable. This manuscript does not contain any identifiable individual information and the IRB of East Carolina University has waived the requirement for consent.

: The authors declare that they have no competing in interests.

Document is current

Any future updates will be listed below